/ricerca/ansaen/search.shtml?any=
Show less

Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Italy halts export of 250,000 AstraZeneca shots

Italy halts export of 250,000 AstraZeneca shots

First in EU to make move under new mechanism

BRUSSELS, 04 March 2021, 17:45

Redazione ANSA

ANSACheck

AstraZeneca © ANSA/EPA

AstraZeneca © ANSA/EPA
AstraZeneca © ANSA/EPA

Italy on Friday told the European Commission it was blocking the export of over 250,000 doses of the AstraZeneca COVID-19 vaccine to Australia, the first EU member to make such a move, and the EC accepted the proposal, sources said Thursday.
    The shots were due to go to Australia.
    Italy's proposal was made in line with the new European mechanism on export controls.
    Rome made the move in light of the current dearth of COVID vaccines, delays to AstraZeneca deliveries in Europe, the high number of shots involved compared to what has so far been supplied to Italy and the EU, and the fact that Australia is not a vulnerable country.
    The Commission has fiercely criticised the Anglo-Swedish company this year for supplying just a fraction of the vaccine doses it had promised to deliver to the bloc.
    The doses came from a plant in Italy operated by AstraZeneca to produce some of its vaccine, one of three authorised for use in the EU alongside the BioNTech/Pfizer and Moderna versions, AFP reported.
    Under the commission's "transparency and authorisation mechanism" EU member states vet planned exports out of the bloc of authorised Covid-19 vaccines. The scheme started on January 30 and is to run until at least the end of March.
    AstraZeneca, which is fully supplying the UK in its world-leading rollout, is currently on just 40% of its pledged 100 million doses to the EU.
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.